Jeffrey Wayne Church - 15 Jan 2026 Form 3 Insider Report for Imunon, Inc. (IMNN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
20 Jan 2026, 16:07:36 UTC
Prior SEC filing
18 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Susan Eylward, Attorney-in-Fact for Jeffrey Church

Key filing fact

Jeffrey Wayne Church filed Form 3 for Imunon, Inc. (IMNN) on 20 Jan 2026.

Key facts

  • This page summarizes Jeffrey Wayne Church's Form 3 filing for Imunon, Inc. (IMNN).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Jan 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 18 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001240203 Primary reporting owner

CHURCH JEFFREY WAYNE

Relationship
CFO
Address
C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE
Signature
/s/ Susan Eylward, Attorney-in-Fact for Jeffrey Church
Signature date
20 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMNN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26
Date
15 Jan 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
167
Exercise price
$9.20
Footnotes
F1
IMNN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$3.95
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .